会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • FAB I INHIBITORS
    • FAB I抑制剂
    • EP1171428B1
    • 2009-06-17
    • EP00928259.1
    • 2000-04-19
    • Affinium Pharmaceuticals, Inc.
    • MILLER, William, H.NEWLANDER, Kenneth, A.SEEFELD, Mark, A.
    • C07D243/14C07D403/12C07D405/12C07D417/12A61K31/5513A61P31/04
    • C07D403/12
    • Compounds of formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections: wherein R1 is H, C¿1-6?alkyl or Ar-C0-6alkyl; R?2¿ is H, C¿1-6?alkyl, Ar-C0-6alkyl, HO-(CH2)n- or R'OC(O)-(CH2)n-; R?3¿ is A-C¿0-4?alkyl, A-C2-4alkenyl, A-C2-4alkynyl, A-C3-4oxoalkenyl, A-C3-4oxoalkynyl, A-C1-4aminoalkyl, A-C3-4aminoalkenyl, A-C3-4aminoalkynyl, optionally substituted by any accessible combination of one or more of R?10 or R7; R4¿ is (a), (b), (c), or (d); R5 is H, C¿1-6?alkyl, Ar-C0-6alkyl or C3-6cycloalkyl-C0-6alkyl; A is H, C3-6cycloalkyl, Het or Ar; R?7 is-COR8¿, -COCR'¿2R?9, -C(S)R8, -S(O)¿k?OR', -S(O)kNR'R'', -PO(OR'),-PO(OR')2, -B(OR')2, -NO2, or tetrazolyl; R?8¿ is -OR', -NR'R'', -NR'SO2R', or -NR'OR', -OCR'¿2?CO(O)R'; R?9¿ is -OR', -CN, -S(O)¿r?R', -S(O)kNR'2, -C(O)R', C(O)NR'2, or -CO2R'; R?10¿ is H, halo, -OR11, -CN, -NR'R11, -NO2, -CF3, CF3S(O)r-, -CO2R', -CONR'2, A-C0-6alkyl-, A-C1-6oxoalkyl-, A-C2-6alkenyl-, A-C2-6alkynyl-, A-C0-6alkyloxy-, A-C0-6alkylamino- or A-C0-6alkyl-S(O)r-; R11 is R', -C(O)R', -C(O)NR'¿2?, -C(O)OR', -S(O)kR', or -S(O)kNR'2; R' is H, C1-6alkyl, Ar-C0-6alkyl or C3-6cycloalkyl-C0-6alkyl; R'' is R', -C(O)R' or -C(O)OR'; R''' is H, C1-6alkyl, Ar-C0-6alkyl, HO-(CH2)2-, R'C(O)-, (R')2NC(O)CH2- or R'S(O)2-; X is H, C1-4alkyl, OR', SR', C1-4alkylsulfonyl, C1-4alkylsulfoxyl, -CN, N(R')2, CH2N(R')2,-NO2,-CF3, -CO2R', -CON(R')2, -COR', -NR'C(O)R', F, C1, Br, I, or CF3S(O)r-; k is 1 or 2; m is 1, 2 or 3; n is 1 to 6; and r is 0, 1 or 2; or a pharmaceutically acceptable salt thereof.